# Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm

> **NCT00511173** · PHASE4 · COMPLETED · sponsor: **Creighton University** · enrollment: 102 (actual)

## Conditions studied

- Atrial Fibrillation
- Pulmonary Embolism
- Deep Vein Thrombosis

## Interventions

- **GENETIC:** Warfarin Dose based on pharmacogenetics

## Key facts

- **NCT ID:** NCT00511173
- **Lead sponsor:** Creighton University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2012-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511173, "Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00511173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*